Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

GenScript

Biotech & Life Sciences · Piscataway Township, United States · Founded 2002 · IPO 2015 Unicorn

GenScript - Make Research Easy - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering.

Valuation
$3.10B
Market cap · May/2026
Revenue
$960M
Latest reported FY
EBITDA
$124M
Latest reported FY

Global footprint

Where GenScript has talent and traffic

AI talent share
0.2% of workforce is AI talent
(2 of 1,323 staff)
Core AI00%
Other AI20.15%
Non-AI workforce1,32199.85%
Workforce by country
25 countries with
team presence
🇺🇸 United States46.7%
🇨🇳 China30.1%
🇸🇬 Singapore10.8%
🇳🇱 Netherlands3.7%
🇬🇧 United Kingdom2.1%
Top 5 of 25 shown

Patent intelligence

$26M patent portfolio · 233 active families

Estimated portfolio value
$26M
0.84% of market cap · 30.1× smaller than top peer BioNTech ($780M)
233 active patent families
Where GenScript innovates Molecular biologyOrganic chemistryBioinformaticsAmino acidChemical compound

Where GenScript concentrates vs peers

Each axis is a top-10 topic across GenScript and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about GenScript

An AI-synthesized read of the highest-engagement posts about GenScript on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GenScript on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.